Sermorelin and ipamorelin get sold against the same short wish list: deeper sleep, quicker recovery, a flatter midsection, better body composition after 40. They act on different receptors, they carry very different regulatory histories, and they reach patients through different supply routes. Those two facts drive most of what you pay and most of the risk you take on.
The useful question in sermorelin vs ipamorelin is not which peptide is stronger. It is which growth hormone signal a clinician is trying to trigger, what evidence exists for your specific goal, and whether the clinic can name the pharmacy that compounded the vial. Work through the factors below in order and the decision usually makes itself.
Start with the goal, not the molecule
Most people arrive with a symptom rather than a diagnosis. Sorting the goal first stops you paying for a protocol that was never designed for it.
- Suspected growth hormone deficiency. That is diagnosed with stimulation testing and IGF-1 measurement, usually by an endocrinologist, not by a wellness intake form.
- Excess visceral fat. One growth hormone releasing hormone analog, tesamorelin, holds a US approval, and it is narrow: reduction of excess abdominal fat in people with HIV-associated lipodystrophy.
- Sleep and recovery. This is where most clinic marketing sits, and where human evidence is thinnest. Expect subjective reports rather than hard endpoints.
- Muscle and strength. Secretagogues raise growth hormone and IGF-1. Raising a hormone is not the same as adding lean mass in a trained adult.
- General anti-aging. Vague goals produce vague protocols and open-ended monthly billing.
Write your goal in one sentence with a number attached: waist circumference, fasting glucose, IGF-1, hours of sleep, training volume. Then judge every clinic on whether it will actually measure that number before and after.
How sermorelin and ipamorelin work on different receptors
Sermorelin is a shortened copy of growth hormone releasing hormone, the natural signal the hypothalamus sends to the pituitary. It docks at the GHRH receptor and asks the pituitary for a pulse of growth hormone. Ipamorelin is a small five amino acid peptide that works at the ghrelin receptor, GHS-R1a, the same switch your hunger hormone uses. Different door, same room.
Both are secretagogues, meaning they ask your own pituitary to release growth hormone rather than delivering the hormone itself. Two practical consequences follow. Your response is capped by how much your pituitary can produce, and it is dampened by somatostatin, the body’s own brake. That is why neither peptide behaves like injected recombinant growth hormone, and why clinics that promise growth hormone therapy results from a secretagogue are overselling.
| Peptide | Class | Target | Reported half-life | US approval history |
|---|---|---|---|---|
| Sermorelin | GHRH analog (first 29 amino acids) | GHRH receptor | Roughly 10 to 20 minutes | Was marketed as a prescription injection, later withdrawn from the market; now typically compounded |
| Ipamorelin | Growth hormone secretagogue, pentapeptide | Ghrelin receptor, GHS-R1a | Reported around 2 hours | No approved US product; used as a compounded preparation |
| CJC-1295 | GHRH analog, sold with or without DAC | GHRH receptor | Short without DAC; reported in days with DAC | No approved US product |
| Tesamorelin | GHRH analog | GHRH receptor | Reported well under an hour | Approved for HIV-associated lipodystrophy under the brand Egrifta |
| Hexarelin | Growth hormone secretagogue | Ghrelin receptor, GHS-R1a | Short | No approved US product; less selective, more effect on prolactin and cortisol |
Selectivity is the standard argument for ipamorelin. In preclinical work it raised growth hormone with little effect on cortisol and prolactin, which separates it from older secretagogues such as hexarelin. The counterargument for sermorelin is that it copies the natural upstream signal, so the pulse pattern stays under the pituitary’s own feedback control. Both arguments are reasonable. Neither is a large randomised trial in healthy adults chasing body composition.
Why it matters: a clinic that cannot explain which receptor its protocol targets probably cannot explain why it chose the dose either.
Approval status quietly decides what a clinic can offer you
This is the factor patients skip and providers rarely volunteer. Sermorelin acetate once had an approved US product that was later pulled from the market for commercial reasons, so compounding pharmacies have a regulatory history to point at. Ipamorelin and CJC-1295 never had an approved US product. Tesamorelin does, for a single specific population.
The Food and Drug Administration maintains lists that decide which bulk substances compounding pharmacies may work with, and several wellness peptides have been placed in the category the agency considers to carry significant safety concerns. That is why some clinics quietly moved patients from ipamorelin and CJC-1295 to sermorelin, and why availability of a given peptide differs between two clinics that otherwise look identical. Ask any provider which substance they dispense today and which pharmacy compounds it.
Quick tip: ask for the compounding pharmacy’s name and state licence in writing before your first payment, then check it against that state’s board of pharmacy register.
No provider matches that filter. .
See every provider we track, with filters and sorting
What sermorelin vs ipamorelin dosage looks like in practice
There is no consumer dosing standard for these peptides, so anyone quoting fixed microgram figures online is describing one clinic’s protocol, not a label. Dosing belongs to the prescriber who reviewed your labs. What you can sensibly compare is the shape of the protocol.
- Route. Both are given by subcutaneous injection, usually from a multi-dose vial reconstituted with bacteriostatic water.
- Timing. Most protocols dose at bedtime because natural growth hormone release peaks during early deep sleep. Some split doses around training.
- Food. A large carbohydrate or fat load close to injection blunts the growth hormone response, so clinics commonly ask for a gap before and after.
- Duration and cycling. Some clinics run continuous months, others cycle with breaks. Ask which, and ask why, before you buy a long supply.
- Titration and review. A protocol that never changes after a lab result is not being managed.
Half-life is the honest reason protocols differ. Sermorelin clears in minutes, which is why it is usually a daily injection. Ipamorelin is reported to persist for around two hours, giving a little more timing flexibility. CJC-1295 with DAC lasts far longer and produces a raised baseline rather than a pulse, which is exactly why some clinicians avoid it: continuous stimulation is less like normal physiology.
Best on clinical care
The quality of the medical side.
- Defy Medical8.2 / 10
- Male Excel7.4 / 10
- Nu Image Medical7 / 10
- Invigor Medical6.4 / 10
- TRT Nation6.2 / 10
Best on support
What happens when something goes wrong.
- Defy Medical6.8 / 10
- Male Excel6.5 / 10
- PeterMD6.5 / 10
- Invigor Medical6.3 / 10
- Nu Image Medical6.2 / 10
Ranked from our own scores, recomputed as data changes. Providers cannot pay for a place.
Stacks: sermorelin with ipamorelin, CJC-1295, and tesamorelin
The rationale for a sermorelin and ipamorelin stack, or the more common CJC-1295 and ipamorelin pairing, is that hitting the GHRH receptor and the ghrelin receptor at once produces a bigger pulse than either alone. Combined GHRH plus secretagogue dosing does raise growth hormone more than single-agent dosing in physiology studies, so the mechanism is not invented. What is missing is outcome evidence in healthy adults: better sleep scores, more lean mass, less visceral fat, measured over months against a control group.
Three things change when you stack. Cost goes up, because you are buying two compounded substances. Attribution goes away, because a side effect cannot be traced to one agent. And the regulatory picture gets more complicated, because the two substances may not sit in the same category for compounding.
Tesamorelin sits apart. It is the only peptide in this group with a US approval and a published label, and that label is specific to HIV-associated lipodystrophy rather than general fat loss. If someone offers you tesamorelin for cosmetic abdominal fat, you are outside the studied population, and the price of the branded product usually makes that obvious.
Belly fat, muscle, and what results to expect
Does sermorelin burn belly fat? Growth hormone does mobilise fat, and higher growth hormone tends to reduce visceral fat, so the direction is plausible. The trial evidence for measured visceral fat reduction with a GHRH analog comes from tesamorelin in people with HIV-associated lipodystrophy, not from sermorelin in the general population. Treat clinic before-and-after photos as marketing, and treat your own waist measurement as data.
Track the number rather than the mirror. Waist to height ratio is cheap, repeatable and more informative about abdominal fat than body weight alone.
Waist-to-height ratio
A single-number check that works across builds better than BMI, with one easy rule: keep your waist under half your height.
Measure at the navel, not at your belt line. Under 0.5 is the widely used cut-off for adults.
Does ipamorelin make you bigger? Not in the way anabolic steroids do. Secretagogues raise growth hormone and downstream IGF-1, and much of the early scale change people report is fluid retention rather than tissue. Growth hormone excess causes real muscle-adjacent effects, including swelling and joint discomfort, and those are not gains. Any lean mass change still depends on training, protein intake and calories, and the peptide will not substitute for those.
If protein intake is the actual gap in your plan, size it before you buy a vial.
What a monthly peptide price actually includes
Advertised monthly figures rarely describe the same package, which is why two clinics can look 40 percent apart and end up level. Break every quote into parts before comparing.
- Medication cost per vial and the number of vials per month
- Consultation fees: initial visit, follow-ups, and whether messaging is included
- Laboratory costs, especially IGF-1, fasting glucose and HbA1c
- Supplies: syringes, needles, alcohol swabs, bacteriostatic water
- Shipping, including cold-chain handling where the pharmacy requires it
- Membership or subscription fees charged whether or not you refill
- Cancellation terms and whether unused months are refundable
Across the clinics tracked here, the spread on sermorelin programs is $149 to $219. Use the annual figure rather than the monthly one, because peptide protocols are rarely a four week decision.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
Insurance, prior authorization, and the cash-pay reality
Compounded peptides are almost always cash-pay. Insurers generally do not cover a compounded preparation that has no approved equivalent, and flexible spending or health savings accounts are the usual workaround rather than a benefit claim. Plan for the full cost yourself.
Coverage is a different conversation for approved products. Growth hormone replacement for diagnosed deficiency and tesamorelin for HIV-associated lipodystrophy can be covered, and both typically involve prior authorization, documented diagnosis, specialist notes and sometimes step therapy before the plan agrees. That paperwork is the price of a covered path, and it is often worth it when you have the diagnosis.
No providers match yet.
See every provider we track, with filters and sorting
Side effects, warnings, interactions, and monitoring
Reported reactions to both peptides are mostly local and mild: pain, redness, itching or swelling at the injection site. Flushing, headache, dizziness and nausea come up with GHRH analogs. Effects that follow raised growth hormone itself are the ones that matter more, because they apply to any successful secretagogue protocol.
- Fluid retention and swelling, often in hands, ankles and face
- Joint and muscle aching, and nerve compression symptoms such as tingling or numbness in the hands
- Higher blood glucose and insulin resistance, which matters if you have prediabetes or diabetes
- Raised IGF-1, which is the marker clinicians watch to avoid pushing beyond a normal range
The approved tesamorelin labeling sets out cautions that sensible prescribers apply across this class: avoid use in pregnancy, avoid use with active malignancy, and take care where the hypothalamic-pituitary axis has been disrupted by surgery, radiation or a tumour. Glucose tolerance can worsen during treatment. Compounded peptides do not come with that labeling, which is a reason to hold them to the same cautions rather than fewer.
Interactions worth raising with your clinician include insulin and other glucose-lowering medicines, corticosteroids, which blunt the growth hormone response, and thyroid hormone replacement. Obesity, high blood sugar and high circulating fatty acids also reduce the pituitary response, so an unchanged result is not always a bad vial.
Competing athletes should stop here: growth hormone secretagogues and growth hormone releasing factors sit on the World Anti-Doping Agency prohibited list, in and out of competition. A clinic prescription is not an exemption.
A reasonable monitoring plan looks like baseline IGF-1, fasting glucose and HbA1c, a repeat at six to twelve weeks, then periodic checks with your waist and weight recorded. Contact your clinician promptly about persistent swelling, new numbness or hand pain, vision changes, unusual headaches, rising blood sugar readings, or any new lump.
Sleep, women, and older adults: the questions clinics hear most
Sleep is the most reported benefit and the least measured one. The physiological hook is real, since most growth hormone is released during deep sleep, and both peptides are usually dosed at night. If sleep is your target, get a baseline for two weeks with a simple log before you start, so you can tell the peptide apart from the fact that you started going to bed earlier.
For women, the mechanism is no different and neither are the cautions. Pregnancy and breastfeeding are firm reasons to stay off these peptides, and anyone trying to conceive should raise it at the consultation rather than after the first vial arrives. Fluid retention and joint aching are the complaints that most often end a protocol early in either sex.
Older adults are the group most often sold on secretagogues, and the group most likely to have a competing explanation for their symptoms. Low testosterone, untreated sleep apnoea, thyroid disease, anaemia, depression and medication side effects all produce the same fatigue and soft body composition that peptide marketing targets. A clinic that screens for those first is doing better medicine than one that goes straight to a vial.
How to sanity-check one provider before you pay
Once your shortlist is down to one or two names, run the same seven checks on each. Most clinics pass or fail inside ten minutes.
- Confirm you will speak with a licensed prescriber, and verify that licence on the state medical board register.
- Ask which peptide, which pharmacy, and whether that pharmacy is a state-licensed 503A compounder or an FDA-registered 503B outsourcing facility.
- Request the certificate of analysis for the batch, including potency and sterility testing.
- Get the twelve month total in writing: medication, consults, labs, supplies, shipping and any membership fee.
- Confirm the lab plan, who orders it, who pays, and what result would stop or change treatment.
- Read the cancellation and refund terms before the first charge, especially on multi-month bundles.
- Ask how side effects are handled: which channel, what response time, and who can adjust the plan.
Red flags are consistent across this market: research-use-only labelling on a product sold for personal use, no lab work required, a fixed protocol quoted before any consultation, guaranteed pound or inch results, pressure to buy six months up front, and a refusal to name the pharmacy.
7 Checks Before You Pay Any Peptide Clinic
- Verify the prescriber's licence on the state medical board register
- Confirm the pharmacy name and whether it is a 503A or 503B facility
- Request the certificate of analysis showing potency and sterility
- Get the 12-month total in writing: medication, consults, labs, supplies, shipping, fees
- Confirm the lab plan, who orders it, and what result would change treatment
- Read cancellation and refund terms before the first charge
- Ask how side effects are handled: channel, response time, and who can adjust the plan
Best on trust and safety
Certification, prescribing and transparency.
- Limitless Life1.5 / 10
- Peptide Sciences1 / 10
Best on ease of use
Signing up, reordering, getting hold of someone.
- Limitless Life5 / 10
- Peptide Sciences1 / 10
Ranked from our own scores, recomputed as data changes. Providers cannot pay for a place.
If neither peptide fits your goal
When the goal is diagnosed growth hormone deficiency, the treatment is growth hormone replacement supervised by an endocrinologist, not a secretagogue bought online. When the goal is visceral fat with an HIV lipodystrophy diagnosis, tesamorelin is the studied option. When the goal is meaningful weight loss, the trial evidence sits with GLP-1 medicines rather than growth hormone peptides, and those have approved products, labels and published outcome data behind them.
Authoritative sources
- FDA guidance on drug compounding and what compounded products are
- FDA human drug compounding information, including bulk substance lists
- World Anti-Doping Agency prohibited list, peptide hormones and growth factors
This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician or pharmacist about your situation, and seek urgent care or call your local emergency number for severe or worsening symptoms.